(Q35999243)

11 August 2017

1 reference

title

Status of immune-based therapies in HIV infection and AIDS. (English)

1 reference

11 August 2017

J L Fahey

1

1 reference

11 August 2017

R Schooley

series ordinal

2

1 reference

11 August 2017

publication date

1 April 1992

1 reference

Clinical and Experimental Immunology

11 August 2017

published in

1 reference

11 August 2017

volume

88

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

1-5

1 reference

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB03029.X

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB03029.X

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB03029.X

The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB03029.X

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB03029.X

A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB03029.X

Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections

21 January 2018

1 reference

12 December 2020

NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines

1 reference

12 December 2020

Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus.

1 reference

12 December 2020

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

12 December 2020

10.1111/J.1365-2249.1992.TB03029.X

Identifiers

DOI

1 reference

11 August 2017

0 references

1 reference